James N. Ingle

1981–2025 年に発表

139
論文数
47,484
被引用数
94
h 指数
137
i10 指数

被引用数

James N. Ingle の年別被引用数1974 年: 被引用 2 件1980 年: 被引用 1 件1981 年: 被引用 2 件1982 年: 被引用 1 件1983 年: 被引用 1 件1984 年: 被引用 3 件1986 年: 被引用 2 件1987 年: 被引用 2 件1988 年: 被引用 7 件1989 年: 被引用 3 件1990 年: 被引用 4 件1991 年: 被引用 4 件1992 年: 被引用 7 件1993 年: 被引用 8 件1994 年: 被引用 3 件1995 年: 被引用 6 件1996 年: 被引用 7 件1997 年: 被引用 9 件1998 年: 被引用 26 件1999 年: 被引用 33 件2000 年: 被引用 53 件2001 年: 被引用 68 件2002 年: 被引用 77 件2003 年: 被引用 147 件2004 年: 被引用 176 件2005 年: 被引用 226 件2006 年: 被引用 311 件2007 年: 被引用 377 件2008 年: 被引用 421 件2009 年: 被引用 410 件2010 年: 被引用 425 件2011 年: 被引用 412 件2012 年: 被引用 370 件2013 年: 被引用 397 件2014 年: 被引用 340 件2015 年: 被引用 371 件2016 年: 被引用 397 件2017 年: 被引用 350 件2018 年: 被引用 325 件2019 年: 被引用 1,117 件2020 年: 被引用 1,184 件2021 年: 被引用 984 件2022 年: 被引用 782 件2023 年: 被引用 541 件2024 年: 被引用 867 件2025 年: 被引用 377 件2026 年: 被引用 12 件1975〜1979 年は被引用が無いため表示していません1985 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,307 件、この内訳の 27.5%中国: 引用元論文 1,252 件、この内訳の 8%イギリス: 引用元論文 1,000 件、この内訳の 6.4%イタリア: 引用元論文 903 件、この内訳の 5.8%ドイツ: 引用元論文 762 件、この内訳の 4.9%カナダ: 引用元論文 665 件、この内訳の 4.2%フランス: 引用元論文 515 件、この内訳の 3.3%オーストラリア: 引用元論文 431 件、この内訳の 2.7%スイス: 引用元論文 420 件、この内訳の 2.7%スペイン: 引用元論文 391 件、この内訳の 2.5%ベルギー: 引用元論文 365 件、この内訳の 2.3%オランダ: 引用元論文 365 件、この内訳の 2.3%
0%27.5%その他 27.4%

分野

  • Medicine47.5%
  • Biochemistry, Genetics and Molecular Biology43.1%
  • Pharmacology, Toxicology and Pharmaceutics2.1%
  • Immunology and Microbiology2%
  • Computer Science1.7%
  • Engineering0.6%
  • その他3%

トピック

  • Breast Cancer Treatment Studies10.8%
  • HER2/EGFR in Cancer Research6.3%
  • Estrogen and related hormone effects4%
  • Advanced Breast Cancer Therapies3.4%
  • Breast Lesions and Carcinomas3.4%
  • Cancer Cells and Metastasis3.1%
  • その他69%

共著者

全論文

検索で開く
  1. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Sibylle Loibl, Monica Morrow, Moïse Namer, C. Kent Osborne, Ann H. Partridge, Frédérique Penault‐Llorca, Charles M. Perou, Martine Piccart, Kathleen I. Pritchard, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Michael Untch, Giuseppe Viale, Toru Watanabe, Nicholas Wilcken, Eric P. Winer, William C. Wood - Annals of Oncology 2013 被引用: 3,715

  2. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mitch Dowsett, Frances Duane, Vaughan Evans, Marianne Ewertz, Bernard Fisher, John Forbes, Leslie G. Ford, J.-C. Gazet, Richard D. Gelber, Lucy Gettins, Luca Gianni, Michael Gnant, Jon Godwin, Aron Goldhirsch, Pamela J. Goodwin, Richard Gray, Daniel F. Hayes, Catherine Hill, James N. Ingle, Reshma Jagsi, R. Jakesz, Sam James, Wolfgang Janni, Hui Liu, Zulian Liu, Caroline Lohrisch, Sibylle Loibl, Liz MacKinnon, Andreas Makris, Eleftherios P. Mamounas, Gurdeep Mannu, Miguel Martín, S. Mathoulin, L. Mauriac, Paul McGale, Theresa McHugh, Philip Morris, Hirofumi Mukai, Larry Norton, Yasuo Ohashi, Ivo A. Olivotto, Soon Young Paik, Hongchao Pan, Richárd Pető, Martine Piccart, Lori J. Pierce, Philip Poortmans, Trevor J. Powles, K.I. Pritchard, Joseph Ragaz, Vinod Raina, Peter M. Ravdin, Simon Read, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Suzy Scholl, Dennis J. Slamon, Lidija Sölkner, Joseph A. Sparano, Seth M. Steinberg, Rosemary Sutcliffe, Sandra M. Swain, Carolyn Taylor, Andrew Tutt, Pinuccia Valagussa, Cornelis J.�H. van de Velde, Jos A. van der Hage, Giuseppe Viale, Gϋnter von Minckwitz ほか 10 名 - The Lancet Oncology 2017 被引用: 1,133

  3. Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2005 被引用: 5,353

  4. Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Monica Morrow, Roberto Orecchia, C. Kent Osborne, Ann H. Partridge, Lorena de la Peña, Martine Piccart, Kathleen I. Pritchard, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Gϋnter von Minckwitz, Toru Watanabe, Timothy J. Whelan, Eric P. Winer, Binghe Xu - Annals of Oncology 2015 被引用: 1,837

  5. Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barbara Ruepp, Angelo Di Leo, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Meredith M. Regan - New England Journal of Medicine 2018 被引用: 673

  6. Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2016 被引用: 645

  7. A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.

    著者: , , , , , , , , , , , , , , , , , , , , , - 2003 被引用: 442

  8. Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jon Godwin, Sam James, Amanda Kerr, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Mariko Nakahara, Simon Read, Hannah Taylor, John Ferguson, H Scheurlen, Stefano Zurrida, Viviana Galimberti, James N. Ingle, Pinuccia Valagussa, Umberto Veronesi, Stewart Anderson, Gong Tang, Bernard Fisher, Sophie D. Fosså, Kristin V. Reinertsen, Herman Høst, Hyman B. Muss, Kaija Holli, Kathy S. Albain, R. Arriagada, John M.S. Bartlett, Elizabeth Bergsten-Nordström, Judith M. Bliss, Étienne Brain, Lisa A. Carey, Robert E. Coleman, Jack Cuzick, Nancy E. Davidson, Lucia Del Mastro, Angelo Di Leo, James J. Dignam, Mitch Dowsett, Bent Ejlertsen, Prue Francis, José Á. García-Sáenz, Rich Gelber, Michael Gnant, Matthew P. Goetz, Pam Goodwin, Pat Halpin-Murphy, Dan Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P. Mamounas, Miguel Martín, Stuart McIntosh, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Martine Piccart, Lori J. Pierce, Vinod Raina, Daniel Rea, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Roberto Salgado, Dennis J. Slamon, Tanja Španić ほか 14 名 - The Lancet 2023 被引用: 151

  9. Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2013 被引用: 740

  10. Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years

    著者: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2016 被引用: 648

  11. Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2003 被引用: 1,564

  12. A comprehensive analysis of breast cancer microbiota and host gene expression

    著者: , , , , , , , , , , , , , , , , , - PLoS ONE 2017 被引用: 179

  13. Exemestane for Breast-Cancer Prevention in Postmenopausal Women

    著者: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2011 被引用: 961

  14. Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 被引用: 727

  15. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

    著者: , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2009 被引用: 1,405

  16. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy

    著者: , , , , , , , , , , , , , , - Clinical Pharmacology & Therapeutics 2018 被引用: 324

  17. Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 被引用: 58

  18. Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2023 被引用: 52

  19. AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells

    著者: , , , , , - Oncogene 2013 被引用: 293

  20. Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response

    著者: , , , , , , , , , , , , , , , , , , , - NAR Cancer 2022 被引用: 43

  21. Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance

    著者: , , , , , , , , , , , , , , , , , , , , - Oncogene 2021 被引用: 102

  22. Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2023 被引用: 44

  23. Phase III Randomized Trial of Bisphosphonates as Adjuvant Therapy in Breast Cancer: S0307

    著者: , , , , , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2019 被引用: 78

  24. Phase III Trial of Doxorubicin, Paclitaxel, and the Combination of Doxorubicin and Paclitaxel as Front-Line Chemotherapy for Metastatic Breast Cancer: An Intergroup Trial (E1193)

    著者: , , , , , , - Journal of Clinical Oncology 2003 被引用: 707